Saga Tsuneo, Nakamoto Yuji, Higashi Tatsuya, Yoshikawa Kyosan
Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba, Japan.
Gastrointest Endosc Clin N Am. 2008 Jul;18(3):479-93, ix. doi: 10.1016/j.giec.2008.05.006.
F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) can play an important role in evaluating patients who have locally advanced diseases and in recurrence detection and restaging in patients who have gastrointestinal tract malignancies. Introduction of an integrated PET/CT system enabled the precise co-evaluation of function and morphology and improved the diagnostic ability of FDG-PET. Application of FDG-PET for treatment response evaluation and prognosis prediction is becoming important. Development of novel PET probes is expected to improve the characterization of individual cancer and to contribute to individualized patient management.
F-18氟脱氧葡萄糖正电子发射断层扫描（FDG-PET）在评估局部晚期疾病患者以及胃肠道恶性肿瘤患者的复发检测和再分期方面可发挥重要作用。集成式PET/CT系统的引入实现了功能与形态的精确联合评估，提高了FDG-PET的诊断能力。FDG-PET在治疗反应评估和预后预测中的应用正变得日益重要。新型PET探针的研发有望改善对个体癌症的特征描述，并有助于个体化患者管理。
